Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
Zuari Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.94 % | 1.16 % | 6.23 % |
|
5yr average Equity Multiplier
|
1.87 | 1.02 | 2.14 |
|
5yr Average Asset Turnover Ratio
|
1.12 | 0.01 | 0.13 |
|
5yr Avg Net Profit Margin
|
11.07 % | 2029.38 % | 18.57 % |
|
Price to Book
|
2.74 | 0.25 | 0.16 |
|
P/E
|
24.16 | 36.11 | 6.27 |
|
5yr Avg Cash Conversion Cycle
|
37.04 Days | -3.66 Days | 181.11 Days |
|
Inventory Days
|
36.45 Days | 33.27 Days | 460.19 Days |
|
Days Receivable
|
65.7 Days | 0.0 | 22.5 Days |
|
Days Payable
|
111.91 Days | 93.13 Days | 209.0 Days |
|
5yr Average Interest Coverage Ratio
|
48.28 | 0.76 | 1.57 |
|
5yr Avg ROCE
|
25.27 % | 1.14 % | 4.23 % |
|
5yr Avg Operating Profit Margin
|
14.8 % | -165.57 % | 5.31 % |
|
5 yr average Debt to Equity
|
0.19 | 0.0 | 0.83 |
|
5yr CAGR Net Profit
|
27.88 % | -59.1 % | 1.66 % |
|
5yr Average Return on Assets
|
12.5 % | 1.14 % | 2.3 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.91 % | 73.79 % | 56.71 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.3 % | 0.01 % | -0.1 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 1.14 % |
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
Zuari Industries
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|